Arrowstreet Capital’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $987K | Buy |
+17,856
| New | +$987K | ﹤0.01% | 1616 |
|
|
2025
Q1 | – | Sell |
-216,069
| Closed | -$8.34M | – | 1970 |
|
|
2024
Q4 | $8.34M | Buy |
216,069
+58,002
| +37% | +$2.24M | 0.01% | 872 |
|
|
2024
Q3 | $7.11M | Buy |
+158,067
| New | +$7.11M | 0.01% | 859 |
|
|
2023
Q3 | – | Sell |
-14,895
| Closed | -$411K | – | 1388 |
|
|
2023
Q2 | $411K | Buy |
+14,895
| New | +$411K | ﹤0.01% | 1084 |
|
|
2020
Q4 | – | Sell |
-66,928
| Closed | -$1.31M | – | 2487 |
|
|
2020
Q3 | $1.31M | Sell |
66,928
-17,489
| -21% | -$342K | ﹤0.01% | 1736 |
|
|
2020
Q2 | $1.49M | Buy |
+84,417
| New | +$1.49M | ﹤0.01% | 1602 |
|
|
2020
Q1 | – | Sell |
-20,000
| Closed | -$141K | – | 2067 |
|
|
2019
Q4 | $141K | Buy |
+20,000
| New | +$141K | ﹤0.01% | 1645 |
|
|
2019
Q1 | – | Sell |
-28,602
| Closed | -$192K | – | 1872 |
|
|
2018
Q4 | $192K | Sell |
28,602
-63,439
| -69% | -$426K | ﹤0.01% | 1256 |
|
|
2018
Q3 | $947K | Buy |
92,041
+8,700
| +10% | +$89.5K | ﹤0.01% | 811 |
|
|
2018
Q2 | $560K | Buy |
+83,341
| New | +$560K | ﹤0.01% | 899 |
|